CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND VINCRISTINE (CAV) FOR RELAPSE IN SMALL-CELL LUNG-CANCER (SCLC) IN PATIENTS TREATED INITIALLY WITH VP-16 AND CISPLATIN (VPP)

被引:0
|
作者
MACCORMICK, R [1 ]
SHEPHERD, FA [1 ]
EVANS, WK [1 ]
FELD, R [1 ]
YAU, J [1 ]
机构
[1] UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA
来源
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE | 1986年 / 9卷 / 03期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A125 / A125
页数:1
相关论文
共 50 条
  • [1] VP-16, VINCRISTINE, ADRIAMYCIN AND CYCLOPHOSPHAMIDE (EVAC) IN PATIENTS WITH SMALL-CELL LUNG-CANCER
    ABADESTEVE, A
    ROSELL, R
    MORENO, I
    FERNANDEZMARCIAL, C
    ROSELLO, MR
    MEDICINA CLINICA, 1988, 90 (14): : 569 - 572
  • [2] COMBINATION CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND VINCRISTINE RAPIDLY ALTERNATING WITH COMBINATION CISPLATIN AND VP-16 IN TREATMENT OF SMALL CELL LUNG-CANCER
    NATALE, RB
    SHANK, B
    HILARIS, BS
    WITTES, RE
    AMERICAN JOURNAL OF MEDICINE, 1985, 79 (03): : 303 - 308
  • [3] ETOPOSIDE (VP-16) AND CISPLATIN - AN EFFECTIVE TREATMENT FOR RELAPSE IN SMALL-CELL LUNG-CANCER
    EVANS, WK
    OSOBA, D
    FELD, R
    SHEPHERD, FA
    BAZOS, MJ
    DEBOER, G
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) : 65 - 71
  • [4] EXPERIENCE WITH VP-16 COMBINED WITH CYCLOPHOSPHAMIDE OR ADRIAMYCIN IN ANAPLASTIC, PREDOMINANTLY SMALL-CELL LUNG-CANCER
    SCHMIEDER, HA
    JUNGI, WF
    MAYR, AC
    SENN, HJ
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1979, 109 (22) : 841 - 844
  • [5] ALTERNATING CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE ADRIAMYCIN VINCRISTINE (CAV) AND CISPLATIN ETOPOSIDE (PVP) AGAINST SMALL-CELL LUNG-CANCER
    BANDO, H
    TAKISHITA, Y
    OGURA, T
    SONE, S
    SHIMIZU, E
    NAKAYAMA, T
    DOI, H
    KOBAYASHI, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1991, 21 (06) : 435 - 439
  • [6] INITIAL THERAPY WITH CISPLATIN PLUS VP-16 IN SMALL-CELL LUNG-CANCER
    EINHORN, LH
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 5 - 9
  • [7] VP-16, IFOSFAMIDE AND CISPLATIN (VIP) FOR EXTENSIVE SMALL-CELL LUNG-CANCER
    EVANS, WK
    STEWART, DJ
    SHEPHERD, FA
    LOGAN, D
    GOSS, G
    MAROUN, JA
    WIERZBICKI, R
    WARNER, E
    LATREILLE, J
    DAHROUGE, S
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (03) : 299 - 303
  • [8] HIGH-DOSE VP-16-213 WITH VINCRISTINE AND ADRIAMYCIN IN THE TREATMENT OF SMALL-CELL LUNG-CANCER (SCLC)
    CALMAN, F
    BELLAMY, D
    FAREBROTHER, M
    TIMOTHY, A
    BATEMAN, N
    RUBENS, R
    COSTELLO, J
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 46 - 46
  • [9] PHASE-II TRIAL OF CISPLATIN AND VP-16 IN PREVIOUSLY TREATED SMALL CELL LUNG-CANCER (SCLC)
    BATIST, G
    IHDE, DC
    COWAN, K
    VEACH, S
    GILLIOM, M
    BUNN, PA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 175 - 175
  • [10] PHASE-III STUDY OF CCNU, CYCLOPHOSPHAMIDE, ADRIAMYCIN, VINCRISTINE, AND VP-16 IN SMALL-CELL CARCINOMA OF THE LUNG
    ETTINGER, DS
    LAGAKOS, S
    CANCER, 1982, 48 (07) : 1544 - 1554